AEE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ameren Corp (AEE) is a good buy right now for a beginner with a long-term focus and $50,000-$100,000 to invest. The stock is trading near support, fundamentals are improving, analysts are broadly constructive, and recent earnings showed solid growth with reaffirmed guidance. While short-term momentum is mixed, the long-term setup is favorable and this is a reasonable entry now rather than waiting.
AEE closed at 108.77, slightly below the pivot at 111.632 and essentially sitting on the first support level at 108.62. MACD histogram is negative and expanding, which means short-term momentum is weak. RSI_6 at 28.544 is near oversold territory, but the report labels it neutral, so it is not a strong reversal signal yet. Moving averages are converging, which usually indicates a potential base-building phase rather than a strong downtrend. Overall, the technical picture is neutral-to-bullish for a long-term entry because price is close to support and downside appears limited near current levels.
Q1 2026 earnings beat on EPS, with non-GAAP EPS of $1.28 up 19.6% YoY. Net income rose to $357 million, up 23.53% YoY, and revenue increased 3.77% YoY. Ameren reaffirmed full-year 2026 EPS guidance of $5.25 to $5.45, which supports confidence in the outlook. Analyst sentiment is constructive, with multiple firms raising targets and issuing Buy/Overweight ratings. Utility sector commentary remains favorable due to data center load growth, infrastructure spending, and improved regulatory outlook.
Revenue came in below expectations in the latest quarter despite positive EPS growth. MACD is still negative and widening, showing near-term price weakness. The stock is not showing a strong breakout pattern yet and is trading just under pivot resistance. Analyst ratings are mixed at the margin, with Morgan Stanley maintaining Equal Weight even while raising its target. No strong insider, hedge fund, or congress buying signal is present.
Latest quarter: Q1 2026. Ameren showed healthy operating improvement. Revenue rose to $2.176 billion, up 3.77% YoY. Net income increased to $357 million, up 23.53% YoY. EPS grew to $1.28, up 20.75% YoY. Gross margin improved to 53.95%, up 6.83% YoY. This is a strong quarter for a regulated utility, with earnings growth clearly outpacing revenue growth, indicating good execution and margin strength.
Analyst sentiment has been positive overall. Truist initiated Buy with a $126 target, BTIG initiated Buy with a $131 target, UBS raised its target to $127 with Buy, Wells Fargo raised to $120 with Overweight, and Argus raised to $115 with Buy. Morgan Stanley and Barclays are more cautious, with Equal Weight/Equal Weight-type stances, though both raised targets to $117 and $116 respectively. The pros view is constructive on Ameren's regulated growth, data center load growth, and transmission opportunity. The main con is valuation discipline and some concern around affordability/political issues, but the broader Wall Street tone is still favorable.
